SANDRIA WARREN: Open Payments
NPI 1841215084 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,502 in 72 payments from 29 companies in 2025. Trend: 2023 $3,202 · 2024 $1,176 · 2025 $1,502
Food & beverage: $1,502
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 9 | $242 |
| Regeneron Healthcare Solutions, Inc. | 7 | $134 |
| Merck Sharp & Dohme LLC | 6 | $128 |
| ABBVIE INC. | 5 | $86 |
| BeOne Medicines USA, Inc. | 4 | $75 |
| Janssen Biotech, Inc. | 3 | $66 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $63 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $60 |
| Celgene Corporation | 3 | $55 |
| PharmaEssentia USA Corporation | 2 | $55 |
Products named: LIBTAYO, REBLOZYL, EPKINLY, KEYTRUDA, BRUKINSA, Nubeqa, FRUZAQLA, PLUVICTO.
Industry payments across AL — which companies pay providers there.
